Welcome to our dedicated page for Cross Country Healthcare news (Ticker: $CCRN), a resource for investors and traders seeking the latest updates and insights on Cross Country Healthcare stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Cross Country Healthcare's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Cross Country Healthcare's position in the market.
Cross Country Healthcare, Inc. (Nasdaq: CCRN) will attend Benchmark's Healthcare House Call Virtual One-on-One Investor Conference on May 21-22, 2024. William J. Burns, Executive Vice President & Chief Financial Officer, and Josh Vogel, Vice President, Investor Relations, will participate in virtual one-on-one investor meetings on Wednesday, May 22, 2024.
Cross Country Healthcare, Inc. (CCRN) announced Q1 2024 financial results, with revenue at $379.2 million, down 39% YoY and 8% sequentially. Gross profit margin was 20.4%, net income at $2.7 million, with diluted EPS at $0.08. Adjusted EBITDA was $15.3 million. Nurse and Allied Staffing revenue decreased 43% YoY, while Physician Staffing revenue increased 16% YoY. The company repurchased 0.3 million shares for $6.4 million.
